These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34949299)

  • 1. Pharmacist-initiated antiretroviral therapy (PIMART).
    Moodley S; Gray A; Schellack N; Schellack N; Venter F; Venter F; Suleman F; Suleman F; Walker RB; Walker RB; Choonara Y; Choonara Y; Truter I; Truter I; Maimin J; Maimin J; Malan SF; Malan SF; Hattingh J; Hattingh J; Meyer JC; Meyer JC; Demana P; Demana P; Kotzé I; Kotzé I; Kubashe N; Kubashe N; Komape TK; Komape TK; Van Wyk S; Van Wyk S; Eksteen M; Eksteen M
    S Afr Med J; 2021 Dec; 111(12):1162-1163. PubMed ID: 34949299
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy.
    Horberg MA; Hurley LB; Silverberg MJ; Kinsman CJ; Quesenberry CP
    J Acquir Immune Defic Syndr; 2007 Apr; 44(5):531-9. PubMed ID: 17224844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAMA takes the lead in HAART provision.
    Bateman C
    S Afr Med J; 2002 Oct; 92(10):750-1. PubMed ID: 12432791
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacist intervention program for hospitalized patients with HIV infection.
    Garey KW; Teichner P
    Am J Health Syst Pharm; 2000 Dec; 57(24):2283-4. PubMed ID: 11146973
    [No Abstract]   [Full Text] [Related]  

  • 5. The cultural and community-level acceptance of antiretroviral therapy (ART) among traditional healers in Eastern Cape, South Africa.
    Shuster JM; Sterk CE; Frew PM; del Rio C
    J Community Health; 2009 Feb; 34(1):16-22. PubMed ID: 18923887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy in South Africa--can we do it?
    Bekker LG; Wood R
    S Afr Med J; 2002 Mar; 92(3):191-3. PubMed ID: 12040936
    [No Abstract]   [Full Text] [Related]  

  • 7. Retention among adults initiating antiretroviral therapy in South Africa: 2002-2007.
    Cornell M; Grimsrud A; Boulle A; Myer L
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):e102; author reply e102-3. PubMed ID: 21317578
    [No Abstract]   [Full Text] [Related]  

  • 8. South Africa will not pay for antiretroviral therapy.
    Sidley P
    BMJ; 2001 Jun; 322(7300):1441. PubMed ID: 11408289
    [No Abstract]   [Full Text] [Related]  

  • 9. Pediatric highly active antiretroviral therapy in Africa: potential benefits of a family-centered model.
    Reddi A; Leeper SC; Sunpath H
    J Infect Dis; 2008 Sep; 198(6):938-9; author reply 939-40. PubMed ID: 18721063
    [No Abstract]   [Full Text] [Related]  

  • 10. Strengthening the health system and ensuring equity in the widescale implementation of an antiretroviral therapy programme in South Africa.
    Schneider H; Coetzee D
    S Afr Med J; 2003 Oct; 93(10):772-3. PubMed ID: 14652966
    [No Abstract]   [Full Text] [Related]  

  • 11. Theorising beyond the individual: adherence to antiretroviral therapy in resource-constrained societies.
    Kagee A; Swartz A; Swartz L
    J Health Psychol; 2014 Jan; 19(1):103-9. PubMed ID: 24058118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.
    Onoya D; Nattey C; Budgell E; van den Berg L; Maskew M; Evans D; Hirasen K; Long LC; Fox MP
    AIDS Patient Care STDS; 2017 May; 31(5):205-212. PubMed ID: 28445088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National adult antiretroviral therapy guidelines in South Africa: concordance with 2003 WHO guidelines?
    Lawn SD; Wood R
    AIDS; 2007 Jan; 21(1):121-2. PubMed ID: 17148984
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV treatment in South African children.
    Neal LJ; Yoganathan K; Roux P
    Lancet; 2004 Jul 3-9; 364(9428):26. PubMed ID: 15234849
    [No Abstract]   [Full Text] [Related]  

  • 15. The dilemma of antiretroviral treatment.
    Ncayiyana DJ
    S Afr Med J; 2001 Jul; 91(7):529. PubMed ID: 11544955
    [No Abstract]   [Full Text] [Related]  

  • 16. "Nothing new": responses to the introduction of antiretroviral drugs in South Africa.
    Chopra M; Kendall C; Hill Z; Schaay N; Nkonki LL; Doherty TM
    AIDS; 2006 Oct; 20(15):1975-7. PubMed ID: 16988520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV treatment in South Africa: overcoming impediments to get started.
    Abdool Karim Q
    Lancet; 2004 Apr; 363(9418):1394. PubMed ID: 15112695
    [No Abstract]   [Full Text] [Related]  

  • 18. The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa.
    Long L; Fox M; Sanne I; Rosen S
    AIDS; 2010 Mar; 24(6):915-9. PubMed ID: 20042849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV in South Africa.
    Satoh S; Boyer E
    Lancet; 2019 Aug; 394(10197):467. PubMed ID: 31402024
    [No Abstract]   [Full Text] [Related]  

  • 20. Do we need a national antiretroviral treatment register?
    Bekker LG; Wood R
    S Afr Med J; 2003 Jul; 93(7):514-5. PubMed ID: 12939922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.